“Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial“ by Griffiths, R. R., Johnson, M. W., et al. (2016) – This randomized double-blind trial investigated the therapeutic potential of psilocybin in reducing depression and anxiety in patients with life-threatening cancer. The study demonstrated significant and sustained decreases in symptoms following psilocybin-assisted psychotherapy.
“Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial“ by Ross, S., Bossis, A., et al. (2016) – This randomized controlled trial examined the efficacy of psilocybin-assisted therapy in reducing symptoms of anxiety and depression in patients with life-threatening cancer. It found rapid and sustained symptom reduction following psilocybin treatment.
“Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors“ by Griffiths, R. R., et al. (2018) – This study explored the combination of psilocybin with meditation and other spiritual practices and its effects on psychological functioning and prosocial attitudes. It found enduring positive changes in these domains.